Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Estrogens
Drug ID BADD_D00831
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID Not Available
MeSH ID D004967
PubChem ID 23676225
TTD Drug ID Not Available
NDC Product Code Not Available
UNII 7XY8FW3E68
Synonyms Estrogens | Estrogenic Compounds | Compounds, Estrogenic | Estrogenic Agents | Agents, Estrogenic | Estrogen | Estrogen Receptor Agonists | Agonists, Estrogen Receptor | Receptor Agonists, Estrogen | Estrogen Effect | Estrogenic Effect | Estrogenic Effects | Effects, Estrogenic | Estrogen Effects | Effects, Estrogen
Chemical Information
Molecular Formula C18H19NaO5S
CAS Registry Number 12126-59-9
SMILES CC12CCC3C(=CCC4=C3C=CC(=C4)OS(=O)(=O)[O-])C1CCC2=O.[Na+]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Dyspepsia07.01.02.001--
Endometrial cancer21.07.02.002; 16.12.02.001--Not Available
Endometrial disorder21.07.01.001--Not Available
Endometrial hyperplasia21.07.01.002--Not Available
Epilepsy17.12.03.002--Not Available
Eructation07.01.02.003--
Erythema multiforme23.03.01.003; 10.01.03.015--
Erythema nodosum23.07.02.001; 10.02.01.020--Not Available
Eye discharge06.04.05.001--Not Available
Fibrocystic breast disease16.14.01.003; 21.05.04.018--Not Available
Flatulence07.01.04.002--
Galactorrhoea05.03.04.002; 21.05.02.002--Not Available
Gallbladder disorder09.03.02.001--Not Available
Generalised oedema14.05.06.007; 08.01.07.004--
Glucose tolerance impaired14.06.02.001; 05.06.02.001--
Gynaecomastia21.05.04.003; 05.05.02.003--
Haemangioma of liver24.03.06.006; 16.06.01.003; 09.04.01.003--Not Available
Headache17.14.01.001--
Hirsutism23.02.04.001; 05.05.01.005--
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hypersensitivity10.01.03.003--
Hypertension24.08.02.001--
Hypertonia17.05.02.001; 15.05.04.007--Not Available
Increased appetite14.03.01.003; 08.01.09.027--Not Available
Insomnia17.15.03.002; 19.02.01.002--
Irritability08.01.03.011; 19.04.02.013--
Jaundice cholestatic09.01.01.005--Not Available
Meningioma benign17.18.03.001; 16.09.03.001--Not Available
Migraine24.03.05.003; 17.14.02.001--Not Available
Muscle spasms15.05.03.004--
The 2th Page    First    Pre   2 3 4    Next   Last    Total 4 Pages